Rifaximin oral tablet

DRUG2 trials

Sponsors

National University Hospital, Singapore, Yokohama City University

Conditions

Chronic Intestinal Pseudo-obstructionIrritable Bowel Syndrome With Diarrhea

Phase 2

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Yokohama City UniversityChronic Intestinal Pseudo-obstruction

Start: 2019-12-25End: 2022-01-31Target: 12Updated: 2021-06-21

Phase 4

Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome

CompletedNCT03557788

National University Hospital, SingaporeIrritable Bowel Syndrome With Diarrhea

Start: 2018-05-07End: 2021-08-13Updated: 2022-04-19